Cargando…

Filtering of the Gene Signature as the Predictors of Cisplatin-Resistance in Ovarian Cancer

BACKGROUND: Gene expression profiling and prediction of drug responses based on the molecular signature indicate new molecular biomarkers which help to find the most effective drugs according to the tumor characteristics. OBJECTIVES: In this study two independent datasets, GSE28646 and GSE15372 were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ataei, Atousa, Arab, Seyed Shahriar, Zahiri, Javad, Rajabpour, Azam, Kletenkov, Konstantin, Rizvanov, Albert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Institute of Genetic Engineering and Biotechnology 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590720/ https://www.ncbi.nlm.nih.gov/pubmed/34825010 http://dx.doi.org/10.30498/ijb.2021.209370.2643

Ejemplares similares

Topological Analysis of Regulatory Networks Reveals Functionally Key Genes and miRNAs Involved in the Differentiation of Mesenchymal Stem Cells
por: Ataei, Atousa, et al.
Publicado: (2021)

Different Approaches to Modulation of Microglia Phenotypes After Spinal Cord Injury
por: Akhmetzyanova, Elvira, et al.
Publicado: (2019)

RepCOOL: computational drug repositioning via integrating heterogeneous biological networks
por: Fahimian, Ghazale, et al.
Publicado: (2020)

Reconstruction of Intercellular Signaling Network by Cytokine-Receptor Interactions
por: Azadian, Somayeh, et al.
Publicado: (2021)

PSSMCOOL: a comprehensive R package for generating evolutionary-based descriptors of protein sequences from PSSM profiles
por: Mohammadi, Alireza, et al.
Publicado: (2022)

EGFR Blockade Reverses Cisplatin Resistance in Human Epithelial Ovarian Cancer Cells
por: Poursheikhani, Arash, et al.
Publicado: (2020)

Apoptosis Induction with Combined Use of Cisplatin and Fisetin in Cisplatin-Resistant Ovarian Cancer Cells (A2780)
por: Jafarzadeh, Samira, et al.
Publicado: (2021)

Transcriptome Profiling Reveals Pro-Inflammatory Cytokines and Matrix Metalloproteinase Activation in Zika Virus Infected Human Umbilical Vein Endothelial Cells
por: Khaiboullina, Svetlana, et al.
Publicado: (2019)

Cisplatin Resistant Patterns in Ovarian Cell Line Using FTIR and Principle Component Analysis
por: Zendehdel, Rezvan, et al.
Publicado: (2012)

Δccr5 Genotype Is Associated with Mild Form of Nephropathia Epidemica
por: Kletenkov, Konstantin, et al.
Publicado: (2019)

Cisplatin/carboplatin cross-resistance in ovarian cancer.
por: Gore, M. E., et al.
Publicado: (1989)

Downstream Effectors of ILK in Cisplatin-Resistant Ovarian Cancer
por: Reyes-González, Jeyshka M., et al.
Publicado: (2020)

Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian Cancer
por: Schweer, David, et al.
Publicado: (2021)

Sensitization of Resistance Ovarian Cancer Cells to Cisplatin by Biogenic Synthesized Silver Nanoparticles through p53 Activation
por: Ramezani, Tayebe, et al.
Publicado: (2019)

Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer
por: Xia, Xi, et al.
Publicado: (2011)

Characteristics and Resistance to Cisplatin of Human Neuroblastoma Cells Co-Cultivated with Immune and Stromal Cells
por: Kitaeva, Kristina V., et al.
Publicado: (2022)

Expression of Ferredoxin1 in cisplatin‑resistant ovarian cancer cells confers their resistance against ferroptosis induced by cisplatin
por: Takahashi, Ryosuke, et al.
Publicado: (2023)

lncRNAs are novel biomarkers for differentiating between cisplatin-resistant and cisplatin-sensitive ovarian cancer
por: Li, Qing, et al.
Publicado: (2018)

Isoalantolactone Suppresses Glycolysis and Resensitizes Cisplatin-Based Chemotherapy in Cisplatin-Resistant Ovarian Cancer Cells
por: Chun, Jaemoo
Publicado: (2023)

Proteomic profiling of the rat hippocampus from the kindling and pilocarpine models of epilepsy: potential targets in calcium regulatory network
por: Sadeghi, Leila, et al.
Publicado: (2021)

Triggering necroptosis in cisplatin and IAP antagonist-resistant ovarian carcinoma
por: McCabe, K E, et al.
Publicado: (2014)

Therapeutic Challenges for Cisplatin-Resistant Ovarian Germ Cell Tumors
por: De Giorgi, Ugo, et al.
Publicado: (2019)

Niclosamide (NA) overcomes cisplatin resistance in human ovarian cancer
por: Huang, Linjuan, et al.
Publicado: (2023)

MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin
por: Konoshenko, Maria, et al.
Publicado: (2022)

Metformin combined with p38 MAPK inhibitor improves cisplatin sensitivity in cisplatin-resistant ovarian cancer
por: XIE, YA, et al.
Publicado: (2014)

Resensitization of cisplatin resistance ovarian cancer cells to cisplatin through pretreatment with low‐dose fraction radiation
por: Zhao, Lili, et al.
Publicado: (2019)

Potentiation of Cisplatin Cytotoxicity in Resistant Ovarian Cancer SKOV3/Cisplatin Cells by Quercetin Pre-Treatment
por: Hasan, Aseel Ali, et al.
Publicado: (2023)

Effectiveness of Remdesivir in Comparison with Five Approved Antiviral Drugs for Inhibition of RdRp in Combat with SARS-CoV-2
por: Mahdian, Soodeh, et al.
Publicado: (2022)

Solvent-dependent activity of Candida antarctica lipase B and its correlation with a regioselective mono aza-Michael addition - experimental and molecular dynamics simulation studies
por: Nazarian, Zohreh, et al.
Publicado: (2022)

EasyModel: a user-friendly web-based interface based on MODELLER
por: Arab, Seyed Shahriar, et al.
Publicado: (2023)

Molecular epidemiology; New but impressive
por: Honardoost, Maryam, et al.
Publicado: (2018)

Alantolactone and ZnO nanoparticles induce apoptosis activity of cisplatin in an ovarian cancer cell line (SKOV3)
por: Alipour, Shahriar, et al.
Publicado: (2022)

Proteasome Inhibitor YSY01A Enhances Cisplatin Cytotoxicity in Cisplatin-Resistant Human Ovarian Cancer Cells
por: Huang, Wei, et al.
Publicado: (2016)

Deregulation of Exo70 Facilitates Innate and Acquired Cisplatin Resistance in Epithelial Ovarian Cancer by Promoting Cisplatin Efflux
por: Zhao, Yujie, et al.
Publicado: (2021)

The Inhibitory Effect of Doxycycline on Cisplatin-Sensitive and -Resistant Epithelial Ovarian Cancer
por: Wu, Wei, et al.
Publicado: (2014)

APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells
por: Mohell, N, et al.
Publicado: (2015)

Upregulation of Fas in epithelial ovarian cancer reverses the development of resistance to Cisplatin
por: Yang, Fan, et al.
Publicado: (2015)

Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells
por: BAO, LINGJIE, et al.
Publicado: (2015)

TRP14 promotes resistance to cisplatin by inducing autophagy in ovarian cancer
por: Tan, Wen-Xi, et al.
Publicado: (2019)

DNA methylation and Transcriptome Changes Associated with Cisplatin Resistance in Ovarian Cancer
por: Lund, Riikka J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vvoajkd9lbgdbompam7kv3n35p